logologo
QuantliQuantli

Neurocrine Biosciences Inc

NBIX

NASDAQ

Biotechnology

$152.72

USD

+1.90 (+1.26%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $15.51B

Volume 1.3M

Price Target

$170.00$221.00

USD

The 5 analysts offering 1-year price forecasts have a max estimate of $221.00 and a min estimate of $170.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$198.20

+$10.1 vs prior

Implied Upside

+29.8%

+6.6% vs prior

Analyst Covering

5

-8 vs prior period

Consensus

Buy

Declined vs prior

Signal Quality

Consensus Freshness

28%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$5.80 Gap

Median $204.00 vs avg $198.20 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

1

Sell

0

Strong Sell

0

5 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Ami Fadia

Needham

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

Evan Seigerman

BMO Capital

Hold

Maintained

4 weeks ago

Plus
Plus
Plus

Corinne Johnson

Goldman Sachs

Buy

Resumed

2 months ago

Plus
Plus
Plus

Brian Abrahams

RBC Capital

Buy

Maintained

2 months ago

Plus
Plus
Plus

Jeffrey Walch

Bernstein

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

UTHR

United Therapeutics Corp

$499.73

-0.3%

BMRN

BioMarin Pharmaceutical Inc

$67.36

-1.7%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

ARWR

Arrowhead Pharmaceuticals Inc

$86.64

+1.2%

MRNA

Moderna Inc

$63.32

-0.5%

EXEL

Exelixis Inc

$51.24

+1.2%

MDGL

Madrigal Pharmaceuticals Inc

$507.56

+0.0%

HALO

Halozyme Therapeutics Inc

$98.66

-2.0%

INCY

Incyte Corp

$120.16

-0.3%